Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
peak-to-trough ratio | peak concentration divided by trough concentration for the stated interval | The peak-to-trough ratio uses two results from the same dosing interval. | Assessment | Drug concentrations, exposure and assay interpretation |
population pharmacokinetic model | model of typical drug disposition and its variation across people | The team documented which population pharmacokinetic model informed the estimate. | Assessment | Drug concentrations, exposure and assay interpretation |
positive likelihood ratio | factor by which a positive result changes the odds of disease | The published positive likelihood ratio applies to the validated cutoff used for this assay. | Assessment | Diagnostic reasoning and strength of evidence |
posterior estimate | updated model estimate after incorporating observed data | The posterior estimate incorporated the verified sample timing. | Assessment | Drug concentrations, exposure and assay interpretation |
prediction interval | range intended to cover a future observation under a specified model | The observed concentration was compared with the model's prediction interval. | Assessment | Drug concentrations, exposure and assay interpretation |
prodrug | compound converted in the body to an active form | The prescribed product is a prodrug and the assay measures its metabolite. | Assessment | Medication exposure, response and adverse-effect reasoning |
relative bioavailability | systemic availability of one preparation compared with a reference preparation | The formulation comparison reports relative bioavailability. | Assessment | Drug concentrations, exposure and assay interpretation |
reportable range | interval over which the laboratory reports a validated measurement | The result exceeds the upper end of the assay's reportable range. | Objective | Drug levels - analyte, specimen and reporting |
reporting limit | boundary beyond which the laboratory uses a qualified result | The value is below the reporting limit and is retained with its inequality sign. | Assessment | Drug concentrations, exposure and assay interpretation |
residual error | difference or unexplained variation between observed and model-predicted values | The model review examined residual error across early and late samples. | Assessment | Drug concentrations, exposure and assay interpretation |
rheumatoid factor | autoantibody measured in selected rheumatologic evaluations | The rheumatoid factor result is listed with the assay's reference interval. | Objective | Muscle, joint fluid and inflammatory measurements |
seroconversion | change from antibody-negative to antibody-positive on sequential testing | Paired samples document seroconversion by the same assay. | Objective | Microbiology and specimen interpretation |
serologic response | change in antibody-based test results over time | The specialist will interpret the serologic response using paired assays. | Assessment | Infection, inflammation and evidence interpretation |
specimen carryover | residual material from another sample affects a measurement | The laboratory investigated possible specimen carryover after the unexpected result. | Assessment | Drug concentrations, exposure and assay interpretation |
systemic clearance | volume of plasma effectively cleared of drug per unit time | The exposure estimate assumes that systemic clearance remained stable over the interval. | Assessment | Drug concentrations, exposure and assay interpretation |
terminal elimination slope | slope of the final log-linear portion of the concentration curve | The terminal elimination slope was estimated from the selected late samples. | Assessment | Drug concentrations, exposure and assay interpretation |
terminal half-life | time for concentration to halve during the terminal log-linear phase | The report gives a terminal half-life based on the final sampling interval. | Assessment | Drug concentrations, exposure and assay interpretation |
thyroid peroxidase antibody | antibody against thyroid peroxidase associated with thyroid autoimmunity | The thyroid peroxidase antibody was documented with the result and assay cutoff. | Objective | Glucose monitoring, endocrine testing and urine studies |
time above threshold | duration during which concentration exceeds a specified value | The estimate of time above threshold used the threshold named in the pharmacokinetic report. | Assessment | Drug concentrations, exposure and assay interpretation |
topiramate | antiseizure medicine with a measurable blood concentration | The outside topiramate report includes the collection date and assay units. | Objective | Drug levels - named analytes and exposure reports |
trough-to-dose ratio | trough concentration divided by the stated dose | The service documented the dose convention used for the trough-to-dose ratio. | Assessment | Drug concentrations, exposure and assay interpretation |
unbound exposure | exposure attributable to drug not bound to proteins or other constituents | The model estimates unbound exposure from the available free concentrations. | Assessment | Drug concentrations, exposure and assay interpretation |
unit reconciliation | checking and aligning the units used for reported and comparison values | The interpretation awaits unit reconciliation with the original laboratory report. | Assessment | Drug concentrations, exposure and assay interpretation |
upper limit | highest applicable value on a stated scale or interval | The assay upper limit is given in the laboratory comment. | Objective | Drug levels - analyte, specimen and reporting |
von Willebrand factor activity | measure of a specified function of von Willebrand factor | Von Willebrand factor activity was interpreted with the antigen level and assay method. | Objective | Coagulation, antibodies and hemostasis studies |